Oncology
From the Journals
Breast cancer exacts high financial toll worldwide
The rate of financial toxicity was much higher in low- and middle-income countries – affecting 79% of patients.
From the Journals
Genomic clues to poor outcomes in young breast cancer patients
Compared with older women with early stage HR-positive breast cancer, women under 40 years of age had significantly higher frequencies of certain...
Commentary
The 5-year survival rate for pancreatic cancer is increasing
‘Research is making a difference. And we’re making progress against cancer in general,’ says expert.
Latest News
More than 97K new cutaneous melanoma diagnoses expected in 2023
More than 1.3 million people in the United States live with cutaneous melanoma, and the overall 5-year survival is 93.7%.
Latest News
‘Valid option’ for partial breast irradiation in breast cancer
Study authors suggest that 30 Gy in five daily fractions is a ‘valid option’ for patients who received lumpectomy for early breast cancer.
From the Journals
Radiotherapy for early breast cancer: Sharp cutoff at age 70
Radiation therapy was 50% less likely to be prescribed for patients age 70 and older with early-stage breast cancer.
From the Journals
Scientists create ‘vagina on a chip’: What to know
Researchers see the chip as a way to facilitate vaginal health research and open the door to vital new treatments.
From the Journals
Less invasive NSCLC surgery does not compromise survival
New results contrast with those from a previous study from 1995.
News
Three wild technologies about to change health care
Now, in the 23rd year of the 21st century, you might not believe what we’ll be capable of next.
From the Journals
Longer life after bariatric surgery, but suicide risk in young
Death from diabetes was 72% lower in the bariatric surgery patients versus nonsurgery peers.
News from the FDA/CDC
FDA OKs sacituzumab govitecan for HR+ metastatic breast cancer
Label expansion for the Trop-2–directed antibody-drug conjugate was based on the TROPICS-02 trial.